1. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. Issue 10323 (29th January 2022) Authors: Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah;... Journal: Lancet Issue: Volume 399:Issue 10323(2022) Page Start: 447 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Issue 10024 (19th March 2016) Authors: James, Nicholas D; Sydes, Matthew R; Clarke, Noel W; Mason, Malcolm D; Dearnaley, David P; Spears, Melissa R; Ritchie, Alastair W S; Parker, Christopher C; Russell, J Martin; Attard, Gerhardt; de Bono, Johann; Cross, William; Jones, Rob J; Thalmann, George; Amos, Claire; Matheson, David; Millman,... Journal: Lancet Issue: Volume 387:Issue 10024(2016) Page Start: 1163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Considering benefit and risk before routinely recommending SpaceOAR. Issue 1 (January 2021) Authors: Hall, William A; Tree, Alison C; Dearnaley, David; Parker, Christopher C; Prasad, Vinay; Roach, Mack; Lawton, Colleen A F Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Postoperative radiotherapy in prostate cancer – Authors' reply. Issue 10285 (1st May 2021) Authors: Parker, Christopher C; Sargos, Paul; Sydes, Matthew R; Kneebone, Andrew; Vale, Claire Journal: Lancet Issue: Volume 397:Issue 10285(2021) Page Start: 1624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Radiotherapy for metastatic prostate cancer–Authors' reply. Issue 10201 (7th September 2019) Authors: Parker, Christopher C; James, Nicholas D; Brawley, Christopher D; Clarke, Noel W; Parmar, Mahesh K B Journal: Lancet Issue: Volume 394:Issue 10201(2019) Page Start: 830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Issue 10162 (1st December 2018) Authors: Parker, Christopher C; James, Nicholas D; Brawley, Christopher D; Clarke, Noel W; Hoyle, Alex P; Ali, Adnan; Ritchie, Alastair W S; Attard, Gerhardt; Chowdhury, Simon; Cross, William; Dearnaley, David P; Gillessen, Silke; Gilson, Clare; Jones, Robert J; Langley, Ruth E; Malik, Zafar I; Mason, Mal... Journal: Lancet Issue: Volume 392:Issue 10162(2018) Page Start: 2353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial. Issue 10260 (31st October 2020) Authors: Parker, Christopher C; Clarke, Noel W; Cook, Adrian D; Kynaston, Howard G; Petersen, Peter Meidahl; Catton, Charles; Cross, William; Logue, John; Parulekar, Wendy; Payne, Heather; Persad, Rajendra; Pickering, Holly; Saad, Fred; Anderson, Juliette; Bahl, Amit; Bottomley, David; Brasso, Klaus; Chah... Journal: Lancet Issue: Volume 396:Issue 10260(2020) Page Start: 1413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗